DABRAFENIB

DABRAFENIB was reported 21157 times

DABRAFENIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRAF V600E MUTATION POSITIVE 29 0.4754
1 ANAPLASTIC THYROID CANCER 48 0.3967
2 GANGLIOGLIOMA 14 0.2917
3 METASTATIC MALIGNANT MELANOMA 481 0.2091
4 BRAF GENE MUTATION 16 0.1778
5 JEJUNAL ULCER PERFORATION 8 0.1739
6 MELANOMA RECURRENT 57 0.1354
7 MALIGNANT MESENTERIC NEOPLASM 10 0.1316
8 VOGT-KOYANAGI-HARADA DISEASE 25 0.1136
9 PANNICULITIS LOBULAR 9 0.1011
10 SEROUS RETINOPATHY 8 0.0762
11 ASTROCYTOMA, LOW GRADE 12 0.0706
12 MALIGNANT MELANOMA STAGE III 14 0.0690
13 ANAPLASTIC ASTROCYTOMA 10 0.0606
14 PANNICULITIS 138 0.0570
15 SEROUS RETINAL DETACHMENT 47 0.0561
16 NON-SMALL CELL LUNG CANCER RECURRENT 15 0.0530
17 LUNG ADENOCARCINOMA STAGE IV 20 0.0525
18 SARCOID-LIKE REACTION 13 0.0504
19 INTESTINAL METASTASIS 18 0.0496
20 METASTASES TO STOMACH 19 0.0485
21 HAEMANGIOMA OF BONE 9 0.0471
22 VARICELLA VIRUS TEST POSITIVE 8 0.0471
23 ACUTE POLYNEUROPATHY 12 0.0420
24 LEUKODERMA 8 0.0402
25 GLIOMA 25 0.0389
26 METASTASES TO CENTRAL NERVOUS SYSTEM 500 0.0387
27 CUTANEOUS SARCOIDOSIS 16 0.0371
28 METASTASES TO HEART 11 0.0364
29 NODULAR RASH 8 0.0360
30 THYROID CANCER METASTATIC 10 0.0356
31 METASTASES TO SPLEEN 14 0.0339
32 ADRENOMEGALY 7 0.0337
33 METASTASES TO SKIN 34 0.0329
34 ASTROCYTOMA 13 0.0329
35 MALIGNANT MELANOMA 439 0.0327
36 KERATOSIS PILARIS 8 0.0320
37 SMALL CELL CARCINOMA 11 0.0320
38 NON-SMALL CELL LUNG CANCER STAGE IV 11 0.0301
39 PROCALCITONIN INCREASED 35 0.0298
40 METASTASES TO MENINGES 67 0.0294
41 KERATOACANTHOMA 20 0.0292
42 CHORIORETINOPATHY 41 0.0288
43 TISSUE INFILTRATION 8 0.0271
44 URETERAL DISORDER 11 0.0268
45 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 23 0.0258
46 METASTASES TO ADRENALS 23 0.0249
47 AUTOIMMUNE COLITIS 16 0.0248
48 METASTASES TO THE MEDIASTINUM 10 0.0243
49 ERYTHEMA NODOSUM 81 0.0231
50 TUMOUR INVASION 11 0.0226
51 CREATINE KINASE INCREASED 17 0.0221
52 PALMOPLANTAR KERATODERMA 15 0.0207
53 METASTASES TO PANCREAS 9 0.0203
54 UVEITIS 266 0.0196
55 SKIN TOXICITY 110 0.0194
56 DEMYELINATING POLYNEUROPATHY 20 0.0194
57 METASTASES TO PERITONEUM 49 0.0194
58 OCULAR TOXICITY 21 0.0190
59 HYPERPYREXIA 78 0.0184
60 NON-SMALL CELL LUNG CANCER 83 0.0173
61 MALIGNANT NEOPLASM PROGRESSION 1771 0.0173
62 NON-SMALL CELL LUNG CANCER METASTATIC 15 0.0171
63 GRANULOMATOUS LIVER DISEASE 12 0.0170
64 HILAR LYMPHADENOPATHY 15 0.0170
65 METASTASES TO BONE MARROW 8 0.0160
66 HYPERKERATOSIS 86 0.0156
67 METASTASIS 111 0.0155
68 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 7 0.0155
69 ACROCHORDON 20 0.0151
70 SECOND PRIMARY MALIGNANCY 125 0.0150
71 EJECTION FRACTION DECREASED 227 0.0146
72 BRAIN CANCER METASTATIC 10 0.0145
73 IRIDOCYCLITIS 44 0.0139
74 ABDOMINAL LYMPHADENOPATHY 12 0.0138
75 METASTASES TO LYMPH NODES 93 0.0138
76 ACQUIRED GENE MUTATION 18 0.0137
77 METASTASES TO LUNG 157 0.0136
78 HYPOPHYSITIS 27 0.0134
79 DERMATITIS ACNEIFORM 79 0.0130
80 RADIATION SKIN INJURY 15 0.0129
81 INTRACRANIAL MASS 12 0.0127
82 GOUTY ARTHRITIS 10 0.0125
83 METASTASES TO PLEURA 13 0.0124
84 BRAIN NEOPLASM 111 0.0121
85 ILEAL PERFORATION 8 0.0121
86 GASTROINTESTINAL WALL THICKENING 18 0.0120
87 PYREXIA 4146 0.0120
88 CENTRAL SEROUS CHORIORETINOPATHY 8 0.0117
89 CHILLS 1343 0.0114
90 PAPILLARY THYROID CANCER 19 0.0109
91 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 82 0.0109
92 LYMPHANGIOSIS CARCINOMATOSA 11 0.0106
93 BODY TEMPERATURE FLUCTUATION 22 0.0106
94 SKIN PAPILLOMA 42 0.0105
95 TUMOUR HAEMORRHAGE 29 0.0102
96 RECURRENT CANCER 41 0.0100
97 PSEUDOMONAS TEST POSITIVE 8 0.0098
98 IMMUNE-MEDIATED HEPATITIS 19 0.0093
99 PERIPHERAL MOTOR NEUROPATHY 13 0.0093
100 LUNG ADENOCARCINOMA 27 0.0090
101 VITILIGO 21 0.0089
102 RETINOPATHY 33 0.0088
103 SQUAMOUS CELL CARCINOMA 82 0.0087
104 METASTASES TO SPINE 29 0.0086
105 BLOOD CREATINE PHOSPHOKINASE INCREASED 247 0.0086
106 DYSCHROMATOPSIA 7 0.0084
107 HYPERTHERMIA 64 0.0084
108 METASTATIC NEOPLASM 36 0.0083
109 RETINAL DETACHMENT 76 0.0083
110 MELANOCYTIC NAEVUS 36 0.0082
111 EJECTION FRACTION ABNORMAL 10 0.0082
112 METASTASES TO LIVER 143 0.0081
113 RECTAL POLYP 8 0.0081
114 XEROSIS 10 0.0081
115 CHOLANGIOCARCINOMA 12 0.0081
116 BLOOD LACTATE DEHYDROGENASE INCREASED 125 0.0079
117 ASPARTATE AMINOTRANSFERASE ABNORMAL 12 0.0079
118 AMYLASE INCREASED 29 0.0079
119 NEOPLASM SKIN 12 0.0077
120 FEBRILE INFECTION 9 0.0076
121 GLIOBLASTOMA 13 0.0076
122 CONCOMITANT DISEASE AGGRAVATED 47 0.0076
123 SARCOIDOSIS 35 0.0074
124 LYMPHADENOPATHY MEDIASTINAL 14 0.0073
125 CARDIAC DYSFUNCTION 27 0.0072
126 BASAL CELL CARCINOMA 113 0.0072
127 CONCOMITANT DISEASE PROGRESSION 14 0.0072
128 ERYSIPELAS 35 0.0070
129 NEOPLASM 80 0.0070
130 SEBORRHOEIC KERATOSIS 10 0.0069
131 TUMOUR PAIN 9 0.0068
132 PARONYCHIA 30 0.0068
133 THERAPY PARTIAL RESPONDER 104 0.0067
134 LYMPHADENITIS 16 0.0066
135 EFFUSION 9 0.0066
136 METASTASES TO BONE 108 0.0066
137 LEFT VENTRICULAR DYSFUNCTION 44 0.0066
138 FEBRILE CONVULSION 8 0.0066
139 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 25 0.0065
140 MALIGNANT PLEURAL EFFUSION 11 0.0065
141 SPLEEN DISORDER 11 0.0065
142 PAPILLOEDEMA 29 0.0064
143 RETINAL VEIN OCCLUSION 18 0.0063
144 FIBRIN D DIMER INCREASED 22 0.0062
145 NO THERAPEUTIC RESPONSE 74 0.0061
146 THYROID CANCER 73 0.0061
147 SKIN HYPERTROPHY 17 0.0060
148 SKIN DEPIGMENTATION 8 0.0059
149 LIPASE INCREASED 44 0.0057
150 ALANINE AMINOTRANSFERASE ABNORMAL 12 0.0057
151 PRERENAL FAILURE 8 0.0057
152 SQUAMOUS CELL CARCINOMA OF SKIN 34 0.0056
153 BRAIN OEDEMA 71 0.0056
154 NEUROLOGICAL DECOMPENSATION 13 0.0056
155 HEPATIC LESION 24 0.0055
156 BODY TEMPERATURE INCREASED 112 0.0055
157 PANCREATIC ENZYMES INCREASED 8 0.0055
158 C-REACTIVE PROTEIN INCREASED 196 0.0054
159 RETINAL DISORDER 14 0.0054
160 LYMPHOEDEMA 36 0.0052
161 NEURITIS 8 0.0052
162 DERMATITIS EXFOLIATIVE GENERALISED 18 0.0052
163 PNEUMONITIS 138 0.0051
164 CELL DEATH 10 0.0050
165 PIGMENTATION DISORDER 31 0.0050
166 VOCAL CORD PARALYSIS 9 0.0050
167 VITREOUS FLOATERS 49 0.0050
168 GUILLAIN-BARRE SYNDROME 24 0.0050
169 ALVEOLITIS 7 0.0050
170 HEPATOTOXICITY 110 0.0049
171 CHOLESTATIC LIVER INJURY 11 0.0049
172 BRAIN NEOPLASM MALIGNANT 22 0.0049
173 BODY TEMPERATURE ABNORMAL 9 0.0049
174 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 113 0.0048
175 MACULAR OEDEMA 27 0.0048
176 ERYTHEMA MULTIFORME 44 0.0047
177 AXILLARY PAIN 7 0.0047
178 FACIAL PARALYSIS 40 0.0047
179 VENTRICULAR HYPOKINESIA 15 0.0047
180 BLOOD CHLORIDE DECREASED 12 0.0046
181 SKIN MASS 31 0.0046
182 HEPATIC CYTOLYSIS 59 0.0046
183 VITREOUS DETACHMENT 10 0.0046
184 ADRENOCORTICAL INSUFFICIENCY ACUTE 9 0.0046
185 BLOOD ALKALINE PHOSPHATASE INCREASED 114 0.0046
186 HEPATITIS 117 0.0046
187 HOSPICE CARE 45 0.0046
188 CENTRAL NERVOUS SYSTEM LESION 62 0.0045
189 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0045
190 VISUAL IMPAIRMENT 550 0.0044
191 GAMMA-GLUTAMYLTRANSFERASE INCREASED 98 0.0044
192 FAECES HARD 17 0.0044
193 THYROIDITIS 13 0.0043
194 RASH MACULO-PAPULAR 96 0.0043
195 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 10 0.0043
196 LUNG CONSOLIDATION 12 0.0043
197 SMALL INTESTINAL PERFORATION 8 0.0043
198 ACTINIC KERATOSIS 11 0.0042
199 NEPHRITIS 14 0.0042
200 DISSEMINATED INTRAVASCULAR COAGULATION 59 0.0042
201 HEPATOCELLULAR INJURY 59 0.0042
202 BICYTOPENIA 8 0.0041
203 HYPERAEMIA 8 0.0041
204 SMALL INTESTINE CARCINOMA 9 0.0040
205 BLOOD ALBUMIN DECREASED 32 0.0040
206 BACTERIAL SEPSIS 13 0.0040
207 PROTEIN TOTAL DECREASED 15 0.0040
208 GENERAL PHYSICAL CONDITION ABNORMAL 27 0.0040
209 RASH MORBILLIFORM 11 0.0040
210 INTRACRANIAL PRESSURE INCREASED 22 0.0039
211 BRAIN OPERATION 9 0.0039
212 LICHENOID KERATOSIS 9 0.0039
213 POLYNEUROPATHY 47 0.0039
214 CARDIOTOXICITY 35 0.0039
215 LIVER FUNCTION TEST INCREASED 84 0.0039
216 BONE LESION 14 0.0039
217 PHOTOSENSITIVITY REACTION 64 0.0039
218 HYPOALBUMINAEMIA 30 0.0039
219 LYMPHADENOPATHY 136 0.0038
220 NEOPLASM RECURRENCE 13 0.0038
221 INTESTINAL PERFORATION 43 0.0038
222 INVESTIGATION 12 0.0038
223 INGROWING NAIL 9 0.0038
224 DRUG RESISTANCE 97 0.0038
225 BLOOD SODIUM DECREASED 71 0.0038
226 ASPARTATE AMINOTRANSFERASE INCREASED 199 0.0037
227 CHOLESTASIS 71 0.0037
228 PULMONARY MASS 55 0.0037
229 HEPATIC NEOPLASM 12 0.0037
230 RENAL CYST 29 0.0036
231 RHABDOMYOLYSIS 151 0.0036
232 HEPATIC ENZYME ABNORMAL 18 0.0036
233 DISEASE PROGRESSION 423 0.0036
234 MENINGITIS ASEPTIC 16 0.0036
235 OESOPHAGEAL STENOSIS 10 0.0035
236 PARAPLEGIA 10 0.0035
237 MYOSITIS 31 0.0035
238 LUNG OPACITY 9 0.0034
239 STRIDOR 10 0.0034
240 CHOLANGITIS 21 0.0034
241 NODULE 44 0.0034
242 DEATH 2899 0.0034
243 EPIGASTRIC DISCOMFORT 13 0.0033
244 MYOCARDITIS 38 0.0033
245 KERATITIS 10 0.0033
246 EYE OEDEMA 8 0.0033
247 NIGHT SWEATS 104 0.0032
248 BLOOD CREATININE DECREASED 10 0.0032
249 NECK MASS 9 0.0032
250 NEOPLASM MALIGNANT 211 0.0032
251 DYSPHAGIA 300 0.0032
252 HYPERREFLEXIA 11 0.0032
253 ADENOCARCINOMA 7 0.0031
254 RADICULOPATHY 8 0.0030
255 ABDOMINAL TENDERNESS 15 0.0030
256 TRANSAMINASES INCREASED 67 0.0030
257 FEELING OF DESPAIR 14 0.0030
258 THROMBOCYTOSIS 11 0.0030
259 PERFORMANCE STATUS DECREASED 14 0.0030
260 ATRIOVENTRICULAR BLOCK FIRST DEGREE 13 0.0030
261 ALANINE AMINOTRANSFERASE INCREASED 183 0.0030
262 HYPOPHOSPHATAEMIA 22 0.0030
263 APHTHOUS ULCER 23 0.0030
264 IRITIS 9 0.0030
265 SKIN LESION 81 0.0029
266 ELECTROCARDIOGRAM QT PROLONGED 106 0.0029
267 B-CELL LYMPHOMA 10 0.0029
268 MULTIPLE-DRUG RESISTANCE 9 0.0029
269 GRANULOMA 10 0.0029
270 TUBULOINTERSTITIAL NEPHRITIS 54 0.0029
271 GENERAL PHYSICAL HEALTH DETERIORATION 333 0.0029
272 PARTIAL SEIZURES 15 0.0029
273 INCORRECT DOSAGE ADMINISTERED 14 0.0029
274 PHOTOPSIA 18 0.0028
275 MENINGITIS 19 0.0028
276 SERUM FERRITIN INCREASED 15 0.0028
277 PANCREATIC DISORDER 14 0.0028
278 TERMINAL STATE 19 0.0028
279 CEREBRAL HAEMORRHAGE 101 0.0028
280 PNEUMATOSIS INTESTINALIS 8 0.0028
281 MONOCYTE COUNT INCREASED 10 0.0028
282 BOWEL MOVEMENT IRREGULARITY 21 0.0027
283 CANCER PAIN 7 0.0027
284 MAJOR DEPRESSION 20 0.0027
285 HEPATIC FUNCTION ABNORMAL 102 0.0027
286 AUTOIMMUNE HEPATITIS 19 0.0027
287 RASH 1189 0.0027
288 IMMUNE-MEDIATED ENTEROCOLITIS 10 0.0027
289 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
290 DUODENAL ULCER 19 0.0027
291 LYMPHOPENIA 38 0.0027
292 TOXIC SKIN ERUPTION 27 0.0027
293 NEOPLASM PROGRESSION 92 0.0026
294 DEHYDRATION 351 0.0026
295 ABDOMINAL MASS 7 0.0026
296 RASH PUSTULAR 19 0.0026
297 ENCEPHALITIS 18 0.0026
298 HYDROCEPHALUS 14 0.0026
299 CEREBRAL DISORDER 19 0.0026
300 DECREASED APPETITE 592 0.0025
301 PYELONEPHRITIS 22 0.0025
302 CACHEXIA 13 0.0025
303 PEMPHIGOID 19 0.0025
304 FEEDING DISORDER 51 0.0025
305 VISION BLURRED 343 0.0025
306 EATING DISORDER 53 0.0025
307 HYPERTHYROIDISM 36 0.0025
308 SPLENOMEGALY 29 0.0025
309 ADRENAL INSUFFICIENCY 30 0.0025
310 LIVER DISORDER 109 0.0025
311 COLITIS 93 0.0025
312 LARGE INTESTINE PERFORATION 17 0.0024
313 NEUTROPHIL COUNT INCREASED 25 0.0024
314 HYPERURICAEMIA 10 0.0024
315 LOCALISED OEDEMA 11 0.0024
316 CARDIOMYOPATHY 35 0.0024
317 MUCOSAL INFLAMMATION 62 0.0024
318 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
319 AORTIC VALVE INCOMPETENCE 10 0.0023
320 ENTERITIS 15 0.0023
321 HEPATIC PAIN 10 0.0023
322 PRODUCT TEMPERATURE EXCURSION ISSUE 12 0.0023
323 APHASIA 70 0.0023
324 EMBOLISM VENOUS 7 0.0023
325 TENDERNESS 24 0.0023
326 PROSTATOMEGALY 9 0.0023
327 LUNG NEOPLASM MALIGNANT 94 0.0023
328 HEPATIC ENZYME INCREASED 155 0.0023
329 PAPULE 16 0.0023
330 LYMPHOCYTE COUNT DECREASED 40 0.0023
331 HYPONATRAEMIA 126 0.0022
332 EPILEPSY 68 0.0022
333 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
334 INFLAMMATORY MARKER INCREASED 11 0.0022
335 VISUAL FIELD DEFECT 16 0.0022
336 WHITE BLOOD CELL COUNT ABNORMAL 14 0.0022
337 HYPERAESTHESIA 18 0.0022
338 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
339 HEMIPLEGIA 18 0.0022
340 HYPERTRANSAMINASAEMIA 15 0.0022
341 DERMATITIS 45 0.0021
342 MASS 30 0.0021
343 PRODUCT USE IN UNAPPROVED INDICATION 531 0.0021
344 VOMITING 995 0.0021
345 HYPERGLYCAEMIA 76 0.0021
346 MYOPATHY 18 0.0021
347 OEDEMA 113 0.0021
348 CEREBRAL HAEMATOMA 7 0.0021
349 DERMATITIS BULLOUS 15 0.0021
350 BONE CANCER 9 0.0021
351 OPTIC ISCHAEMIC NEUROPATHY 8 0.0021
352 LIVER FUNCTION TEST ABNORMAL 60 0.0021
353 SPEECH DISORDER 108 0.0021
354 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 53 0.0021
355 UROSEPSIS 19 0.0021
356 URINE OUTPUT DECREASED 18 0.0021
357 SEIZURE 236 0.0020
358 HEPATOMEGALY 20 0.0020
359 FUNCTIONAL GASTROINTESTINAL DISORDER 7 0.0020
360 HYPERCALCAEMIA 25 0.0020
361 PHOTOPHOBIA 38 0.0020
362 LEUKOPENIA 101 0.0020
363 HEMIPARESIS 34 0.0020
364 TYPE 1 DIABETES MELLITUS 12 0.0020
365 PULMONARY TOXICITY 14 0.0020
366 HYPOTHYROIDISM 63 0.0020
367 BUNDLE BRANCH BLOCK RIGHT 9 0.0020
368 ASTHENIA 733 0.0019
369 CHROMATURIA 44 0.0019
370 FEELING COLD 54 0.0019
371 THERAPY CHANGE 19 0.0019
372 PANCREATITIS 102 0.0019
373 EMBOLISM 16 0.0019
374 YELLOW SKIN 9 0.0019
375 BLOOD PHOSPHORUS DECREASED 7 0.0019
376 INCORRECT DRUG ADMINISTRATION RATE 8 0.0019
377 INTERSTITIAL LUNG DISEASE 91 0.0019
378 MELAENA 41 0.0019
379 FATIGUE 1445 0.0019
380 DRUG INTOLERANCE 179 0.0019
381 AUTOIMMUNE THYROIDITIS 7 0.0018
382 ALTERED STATE OF CONSCIOUSNESS 40 0.0018
383 SKIN REACTION 26 0.0018
384 CYTOKINE RELEASE SYNDROME 37 0.0018
385 RASH MACULAR 64 0.0018
386 PNEUMOTHORAX 29 0.0018
387 HAEMOPTYSIS 51 0.0018
388 HEPATIC FAILURE 55 0.0018
389 THROMBOCYTOPENIA 204 0.0018
390 PLEURAL EFFUSION 111 0.0018
391 HYPOACUSIS 78 0.0018
392 FOLLICULITIS 19 0.0018
393 PERIPHERAL SWELLING 279 0.0018
394 ELECTROLYTE IMBALANCE 21 0.0018
395 NAUSEA 1414 0.0018
396 EYE INFLAMMATION 17 0.0018
397 HYPOTHERMIA 18 0.0018
398 BLOOD BILIRUBIN INCREASED 48 0.0018
399 VISUAL ACUITY REDUCED 59 0.0018
400 MYALGIA 301 0.0018
401 PULMONARY EMBOLISM 168 0.0018
402 THERAPY CESSATION 90 0.0018
403 NEPHROTIC SYNDROME 12 0.0017
404 INFLAMMATION 90 0.0017
405 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
406 SENSORY LOSS 14 0.0017
407 HAEMORRHAGE INTRACRANIAL 26 0.0017
408 RASH GENERALISED 45 0.0017
409 ASCITES 51 0.0017
410 MUSCLE STRAIN 15 0.0017
411 MULTIPLE ORGAN DYSFUNCTION SYNDROME 49 0.0017
412 METABOLIC DISORDER 10 0.0017
413 EXTRASYSTOLES 12 0.0017
414 POLYURIA 14 0.0017
415 HYPOVOLAEMIA 10 0.0017
416 POLYARTHRITIS 9 0.0017
417 TUMOUR LYSIS SYNDROME 15 0.0017
418 OCULAR DISCOMFORT 19 0.0017
419 BLOOD CALCIUM DECREASED 19 0.0017
420 SEPSIS 188 0.0017
421 GASTROINTESTINAL PERFORATION 7 0.0017
422 CONGESTIVE CARDIOMYOPATHY 7 0.0017
423 TASTE DISORDER 34 0.0017
424 BLOOD UREA INCREASED 28 0.0017
425 HYPOVOLAEMIC SHOCK 8 0.0017
426 CHEILITIS 9 0.0017
427 PULMONARY HAEMORRHAGE 13 0.0017
428 FACE OEDEMA 28 0.0017
429 CARDIAC FAILURE 133 0.0017
430 BUNDLE BRANCH BLOCK LEFT 7 0.0016
431 NEUTROPENIA 223 0.0016
432 DRUG ERUPTION 29 0.0016
433 INFLAMMATORY BOWEL DISEASE 16 0.0016
434 ULCER 26 0.0016
435 BLOOD CREATININE INCREASED 106 0.0016
436 BLINDNESS 66 0.0016
437 NECROSIS 9 0.0016
438 ORGANISING PNEUMONIA 8 0.0016
439 CYST 20 0.0016
440 PANCREATITIS ACUTE 36 0.0016
441 DIVERTICULUM INTESTINAL 7 0.0016
442 NASAL DRYNESS 10 0.0016
443 CHOLECYSTITIS ACUTE 9 0.0016
444 NEUTROPHILIA 9 0.0016
445 THERAPY INTERRUPTED 113 0.0016
446 INFLUENZA LIKE ILLNESS 130 0.0016
447 SEPTIC SHOCK 68 0.0016
448 DRUG-INDUCED LIVER INJURY 49 0.0016
449 SKIN DISORDER 52 0.0016
450 ANAL INCONTINENCE 14 0.0016
451 ILLNESS 160 0.0016
452 ACUTE KIDNEY INJURY 236 0.0015
453 PRODUCT SUPPLY ISSUE 11 0.0015
454 HYPOTENSION 309 0.0015
455 HYPOKALAEMIA 71 0.0015
456 GINGIVAL BLEEDING 21 0.0015
457 HAEMORRHAGIC STROKE 12 0.0015
458 INFECTION 222 0.0015
459 DIARRHOEA 988 0.0015
460 BLOOD LACTIC ACID INCREASED 8 0.0015
461 NEPHROPATHY TOXIC 17 0.0015
462 PERICARDIAL EFFUSION 35 0.0015
463 CORONAVIRUS INFECTION 10 0.0015
464 CHOLECYSTITIS 18 0.0015
465 TRICUSPID VALVE INCOMPETENCE 12 0.0015
466 APPETITE DISORDER 10 0.0015
467 MITRAL VALVE INCOMPETENCE 17 0.0015
468 GASTRITIS EROSIVE 7 0.0015
469 COAGULOPATHY 25 0.0015
470 CONSTIPATION 326 0.0015
471 OEDEMA PERIPHERAL 182 0.0015
472 EYE DISORDER 49 0.0015
473 LUNG DISORDER 73 0.0015
474 BLINDNESS UNILATERAL 21 0.0015
475 ARTHROPOD BITE 11 0.0015
476 COLITIS ISCHAEMIC 10 0.0015
477 ORAL PAIN 33 0.0015
478 BLOOD POTASSIUM DECREASED 44 0.0015
479 LARYNGEAL OEDEMA 9 0.0015
480 PLATELET COUNT INCREASED 19 0.0015
481 GASTROINTESTINAL TOXICITY 7 0.0015
482 ONYCHOCLASIS 10 0.0015
483 HYPERBILIRUBINAEMIA 15 0.0014
484 EPSTEIN-BARR VIRUS INFECTION 9 0.0014
485 GASTROENTERITIS 21 0.0014
486 URINARY RETENTION 48 0.0014
487 CONFUSIONAL STATE 232 0.0014
488 MALAISE 628 0.0014
489 DRY SKIN 191 0.0014
490 DIPLOPIA 37 0.0014
491 BLOOD TEST ABNORMAL 20 0.0014
492 ARTHRALGIA 590 0.0014
493 VIRAL INFECTION 47 0.0014
494 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
495 NEUROLOGICAL SYMPTOM 8 0.0014
496 SYNCOPE 140 0.0014
497 SKIN CANCER 30 0.0014
498 LIMB DISCOMFORT 43 0.0014
499 ANAEMIA 265 0.0014
500 FLANK PAIN 13 0.0014
501 MOUTH SWELLING 8 0.0014
502 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
503 BACK INJURY 15 0.0014
504 PRODUCT STORAGE ERROR 120 0.0014
505 CELLULITIS 69 0.0014
506 HYPERTRIGLYCERIDAEMIA 8 0.0014
507 GROIN PAIN 12 0.0014
508 ENDOCARDITIS 7 0.0014
509 DRY MOUTH 110 0.0014
510 STOMATITIS 82 0.0014
511 RENAL IMPAIRMENT 113 0.0013
512 ENCEPHALOPATHY 33 0.0013
513 DRY EYE 67 0.0013
514 HAEMATEMESIS 34 0.0013
515 SKIN INFECTION 15 0.0013
516 DYSARTHRIA 50 0.0013
517 STATUS EPILEPTICUS 15 0.0013
518 RENAL FAILURE 176 0.0013
519 PANCYTOPENIA 74 0.0013
520 OPTIC NEURITIS 12 0.0013
521 TENSION 8 0.0013
522 ATRIAL FIBRILLATION 127 0.0013
523 SKIN PLAQUE 11 0.0013
524 GASTRIC HAEMORRHAGE 15 0.0013
525 NEUTROPHIL COUNT DECREASED 53 0.0013
526 CIRCULATORY COLLAPSE 22 0.0013
527 TREMOR 214 0.0013
528 COUGH 361 0.0013
529 SECRETION DISCHARGE 16 0.0013
530 ASTHENOPIA 7 0.0013
531 ACNE 96 0.0013
532 SPUTUM DISCOLOURED 12 0.0013
533 GASTRIC ULCER HAEMORRHAGE 7 0.0013
534 MUSCLE ATROPHY 16 0.0013
535 STEVENS-JOHNSON SYNDROME 28 0.0013
536 HYPERHIDROSIS 162 0.0013
537 COLD SWEAT 22 0.0012
538 DYSPNOEA EXERTIONAL 47 0.0012
539 ATELECTASIS 12 0.0012
540 URINARY TRACT INFECTION 211 0.0012
541 HAEMATURIA 42 0.0012
542 ABNORMAL FAECES 10 0.0012
543 NEUROPATHY PERIPHERAL 116 0.0012
544 SKIN DISCOLOURATION 56 0.0012
545 HICCUPS 10 0.0012
546 NERVOUS SYSTEM DISORDER 38 0.0012
547 ESCHERICHIA INFECTION 10 0.0012
548 ENTEROCOLITIS 7 0.0012
549 BLOOD URIC ACID INCREASED 7 0.0012
550 PROTEINURIA 23 0.0012
551 ILEUS 15 0.0012
552 VASCULITIS 14 0.0012
553 PULMONARY FIBROSIS 23 0.0012
554 HEADACHE 750 0.0012
555 SPINAL PAIN 14 0.0012
556 OESOPHAGITIS 13 0.0012
557 POSTOPERATIVE WOUND INFECTION 8 0.0012
558 BLOOD PRESSURE DECREASED 78 0.0012
559 WHITE BLOOD CELL COUNT INCREASED 45 0.0012
560 RASH ERYTHEMATOUS 56 0.0012
561 ARTERIOSCLEROSIS 11 0.0012
562 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
563 GAIT INABILITY 39 0.0012
564 RASH PAPULAR 26 0.0012
565 GASTRIC ULCER 22 0.0012
566 ACUTE MYELOID LEUKAEMIA 18 0.0012
567 WEIGHT DECREASED 322 0.0012
568 FAECES DISCOLOURED 25 0.0012
569 DELIRIUM 40 0.0012
570 MENTAL STATUS CHANGES 32 0.0012
571 JAUNDICE 31 0.0012
572 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
573 INTERNAL HAEMORRHAGE 13 0.0011
574 ABDOMINAL PAIN 264 0.0011
575 HAIR TEXTURE ABNORMAL 15 0.0011
576 OCULAR HYPERAEMIA 53 0.0011
577 EYE PAIN 63 0.0011
578 DECREASED ACTIVITY 12 0.0011
579 EPISTAXIS 83 0.0011
580 WOUND 31 0.0011
581 SHOCK HAEMORRHAGIC 9 0.0011
582 LEUKOCYTOSIS 20 0.0011
583 PULMONARY THROMBOSIS 12 0.0011
584 FAECES SOFT 8 0.0011
585 INCREASED APPETITE 21 0.0011
586 THROMBOSIS 88 0.0011
587 JOINT SWELLING 132 0.0011
588 PNEUMONIA 354 0.0011
589 EMPHYSEMA 11 0.0011
590 PNEUMONIA BACTERIAL 10 0.0011
591 GASTROINTESTINAL HAEMORRHAGE 91 0.0011
592 HAEMOGLOBIN ABNORMAL 7 0.0011
593 INTESTINAL OBSTRUCTION 41 0.0011
594 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
595 ILL-DEFINED DISORDER 66 0.0011
596 MOTOR DYSFUNCTION 11 0.0011
597 PRODUCT USE COMPLAINT 17 0.0011
598 COLON CANCER 16 0.0011
599 KIDNEY INFECTION 21 0.0011
600 HYDRONEPHROSIS 8 0.0011
601 ASPERGILLUS INFECTION 7 0.0011
602 GASTRITIS 28 0.0011
603 REBOUND EFFECT 12 0.0011
604 LIVER INJURY 26 0.0011
605 HAEMATOCRIT DECREASED 21 0.0011
606 HYPOPHAGIA 27 0.0011
607 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 190 0.0011
608 PRODUCT AVAILABILITY ISSUE 24 0.0011
609 HAEMOGLOBIN DECREASED 108 0.0011
610 GENERALISED OEDEMA 13 0.0010
611 SKIN HYPERPIGMENTATION 9 0.0010
612 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
613 BLOOD MAGNESIUM DECREASED 9 0.0010
614 PLATELET COUNT DECREASED 111 0.0010
615 INCONTINENCE 11 0.0010
616 SUDDEN DEATH 11 0.0010
617 ALOPECIA 203 0.0010
618 LOWER RESPIRATORY TRACT INFECTION 47 0.0010
619 DEAFNESS 27 0.0010
620 TACHYPNOEA 14 0.0010
621 AGRANULOCYTOSIS 19 0.0010
622 ECZEMA 53 0.0010
623 URINARY INCONTINENCE 30 0.0010
624 ATAXIA 12 0.0010
625 BACTERAEMIA 12 0.0010
626 BLOOD PRESSURE ABNORMAL 20 0.0010
627 ADVERSE DRUG REACTION 90 0.0010
628 GASTROINTESTINAL PAIN 11 0.0010
629 VENTRICULAR FIBRILLATION 11 0.0010
630 NOCTURIA 12 0.0010
631 PAIN IN EXTREMITY 290 0.0010
632 DECUBITUS ULCER 8 0.0010
633 ASPHYXIA 8 0.0010
634 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0010
635 LETHARGY 56 0.0010
636 BONE PAIN 57 0.0010
637 ABDOMINAL DISCOMFORT 163 0.0010
638 AMNESIA 63 0.0010
639 SPINAL COMPRESSION FRACTURE 8 0.0010
640 DISEASE RECURRENCE 46 0.0010
641 HEPATIC STEATOSIS 18 0.0010
642 HYPOKINESIA 14 0.0010
643 PULMONARY OEDEMA 43 0.0010
644 ERYTHEMA 197 0.0010
645 SHOCK 22 0.0010
646 THIRST 17 0.0010
647 ARRHYTHMIA 45 0.0009
648 MOUTH ULCERATION 20 0.0009
649 SPINAL FRACTURE 19 0.0009
650 HAEMATOTOXICITY 9 0.0009
651 INTRAOCULAR PRESSURE INCREASED 12 0.0009
652 RETCHING 20 0.0009
653 DISORIENTATION 37 0.0009
654 PSEUDOMONAS INFECTION 8 0.0009
655 WHITE BLOOD CELL COUNT DECREASED 101 0.0009
656 APHONIA 13 0.0009
657 DYSGEUSIA 69 0.0009
658 BLOOD IRON DECREASED 11 0.0009
659 BLISTER 52 0.0009
660 DYSSTASIA 27 0.0009
661 AORTIC ANEURYSM 7 0.0009
662 PERITONITIS 19 0.0009
663 FLATULENCE 52 0.0009
664 CONJUNCTIVITIS 17 0.0009
665 ACIDOSIS 7 0.0009
666 SINUS TACHYCARDIA 13 0.0009
667 MUSCULAR WEAKNESS 104 0.0009
668 BODY TEMPERATURE DECREASED 9 0.0009
669 INCORRECT PRODUCT STORAGE 12 0.0009
670 ASPIRATION 10 0.0009
671 BACTERIAL INFECTION 17 0.0009
672 CYSTITIS 29 0.0009
673 IMMUNE SYSTEM DISORDER 12 0.0009
674 SWELLING 85 0.0009
675 MOVEMENT DISORDER 29 0.0009
676 DIVERTICULITIS 25 0.0009
677 TACHYCARDIA 80 0.0009
678 HYPOCALCAEMIA 17 0.0009
679 BRAIN INJURY 9 0.0009
680 PLASMA CELL MYELOMA 35 0.0009
681 FEBRILE NEUTROPENIA 59 0.0009
682 CARDIAC DISORDER 83 0.0009
683 PHARYNGITIS 11 0.0009
684 GAIT DISTURBANCE 169 0.0009
685 GLAUCOMA 17 0.0009
686 SLUGGISHNESS 9 0.0009
687 LOSS OF CONSCIOUSNESS 113 0.0009
688 SCIATICA 14 0.0009
689 ATRIAL FLUTTER 7 0.0009
690 DERMATITIS ALLERGIC 11 0.0009
691 DYSPHONIA 51 0.0009
692 LIP SWELLING 29 0.0009
693 DYSURIA 32 0.0009
694 OVARIAN CANCER 8 0.0009
695 RASH PRURITIC 47 0.0009
696 DIABETES MELLITUS 66 0.0009
697 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
698 CATARACT 51 0.0009
699 DIARRHOEA HAEMORRHAGIC 8 0.0009
700 FEAR 23 0.0009
701 HOSPITALISATION 131 0.0009
702 FREQUENT BOWEL MOVEMENTS 23 0.0009
703 MENTAL DISORDER 37 0.0008
704 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
705 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
706 RESPIRATORY TRACT INFECTION 22 0.0008
707 SKIN EXFOLIATION 71 0.0008
708 RED BLOOD CELL COUNT DECREASED 24 0.0008
709 MACULAR DEGENERATION 10 0.0008
710 ABDOMINAL PAIN UPPER 172 0.0008
711 SWELLING FACE 54 0.0008
712 THERAPEUTIC RESPONSE DECREASED 50 0.0008
713 EYE HAEMORRHAGE 11 0.0008
714 PAIN 506 0.0008
715 HYPOXIA 29 0.0008
716 PRESYNCOPE 20 0.0008
717 WOUND INFECTION 9 0.0008
718 SCAR 14 0.0008
719 PHARYNGEAL SWELLING 8 0.0008
720 CYTOPENIA 10 0.0008
721 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
722 ANURIA 7 0.0008
723 CARDIOMEGALY 10 0.0008
724 VERTIGO 49 0.0008
725 NERVOUSNESS 42 0.0008
726 MUSCLE TIGHTNESS 13 0.0008
727 PERIPHERAL COLDNESS 11 0.0008
728 BLOOD CALCIUM INCREASED 7 0.0008
729 PRODUCTIVE COUGH 38 0.0008
730 ABDOMINAL PAIN LOWER 20 0.0008
731 MYOCARDIAL ISCHAEMIA 9 0.0008
732 HYPOMAGNESAEMIA 11 0.0008
733 STAPHYLOCOCCAL INFECTION 26 0.0008
734 MICTURITION URGENCY 9 0.0008
735 DRY THROAT 8 0.0008
736 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
737 RESPIRATORY FAILURE 57 0.0008
738 GASTROINTESTINAL DISORDER 70 0.0008
739 HAEMOLYTIC ANAEMIA 7 0.0008
740 GASTROINTESTINAL INFECTION 7 0.0008
741 PAIN OF SKIN 21 0.0008
742 PRURITUS 299 0.0008
743 DIZZINESS 387 0.0008
744 DEPRESSED MOOD 41 0.0008
745 TEMPERATURE INTOLERANCE 8 0.0008
746 COGNITIVE DISORDER 36 0.0008
747 CHOKING 15 0.0008
748 PARALYSIS 11 0.0008
749 MUSCULOSKELETAL PAIN 40 0.0008
750 AGEUSIA 19 0.0008
751 PNEUMONIA ASPIRATION 19 0.0008
752 SARS-COV-2 TEST POSITIVE 10 0.0008
753 HAEMORRHAGE 79 0.0008
754 RENAL PAIN 8 0.0008
755 ADVERSE REACTION 10 0.0008
756 DEEP VEIN THROMBOSIS 49 0.0008
757 DYSPEPSIA 74 0.0008
758 FEELING HOT 46 0.0007
759 BACK PAIN 174 0.0007
760 SENSORY DISTURBANCE 12 0.0007
761 FRACTURE 14 0.0007
762 DISCOMFORT 45 0.0007
763 SKIN ULCER 19 0.0007
764 DYSPNOEA 415 0.0007
765 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
766 PRODUCT USE ISSUE 137 0.0007
767 LOWER LIMB FRACTURE 14 0.0007
768 HAEMATOCHEZIA 40 0.0007
769 ARTHRITIS 57 0.0007
770 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
771 INCORRECT DOSE ADMINISTERED 164 0.0007
772 HUNGER 10 0.0007
773 MALNUTRITION 8 0.0007
774 CARDIAC ARREST 59 0.0007
775 THYROID DISORDER 11 0.0007
776 HYPERTENSION 151 0.0007
777 PALLOR 19 0.0007
778 NEPHROLITHIASIS 32 0.0007
779 CARDIOGENIC SHOCK 10 0.0007
780 CEREBRAL INFARCTION 17 0.0007
781 FULL BLOOD COUNT DECREASED 14 0.0007
782 LOCAL SWELLING 12 0.0007
783 EOSINOPHILIA 12 0.0007
784 HYPERKALAEMIA 24 0.0007
785 HIP FRACTURE 22 0.0007
786 ORAL CANDIDIASIS 9 0.0007
787 HYPOAESTHESIA 102 0.0007
788 OROPHARYNGEAL PAIN 63 0.0007
789 PARAESTHESIA 107 0.0007
790 NASOPHARYNGITIS 125 0.0007
791 BLOOD POTASSIUM INCREASED 11 0.0007
792 POLLAKIURIA 28 0.0007
793 QUALITY OF LIFE DECREASED 9 0.0007
794 SOMNOLENCE 134 0.0007
795 RENAL DISORDER 31 0.0007
796 HYPERSOMNIA 19 0.0007
797 HYPERSENSITIVITY 123 0.0007
798 ERECTILE DYSFUNCTION 17 0.0007
799 NECK PAIN 37 0.0007
800 DRUG INTERACTION 105 0.0007
801 NEURALGIA 16 0.0007
802 FALL 219 0.0007
803 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
804 CANDIDA INFECTION 11 0.0007
805 MEMORY IMPAIRMENT 89 0.0006
806 LYMPHOMA 10 0.0006
807 LUNG INFECTION 10 0.0006
808 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
809 MUSCULOSKELETAL DISCOMFORT 11 0.0006
810 BALANCE DISORDER 55 0.0006
811 BLOOD URINE PRESENT 12 0.0006
812 HEAD INJURY 20 0.0006
813 ACUTE RESPIRATORY FAILURE 12 0.0006
814 TOXICITY TO VARIOUS AGENTS 105 0.0006
815 HEAD DISCOMFORT 11 0.0006
816 APATHY 9 0.0006
817 RESPIRATORY DISTRESS 17 0.0006
818 COMA 29 0.0006
819 TOOTH INFECTION 8 0.0006
820 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
821 PRODUCT ADMINISTRATION ERROR 12 0.0006
822 COVID-19 PNEUMONIA 7 0.0006
823 INFLUENZA 66 0.0006
824 MUSCLE SPASMS 108 0.0006
825 URTICARIA 98 0.0006
826 MYELOSUPPRESSION 21 0.0006
827 CONTUSION 56 0.0006
828 HEART RATE INCREASED 57 0.0006
829 CEREBROVASCULAR ACCIDENT 97 0.0006
830 DEMENTIA 16 0.0006
831 NEUROTOXICITY 10 0.0006
832 FEELING ABNORMAL 136 0.0006
833 EYE SWELLING 21 0.0006
834 ABSCESS 9 0.0006
835 ORAL HERPES 11 0.0006
836 SKIN FISSURES 11 0.0006
837 HOT FLUSH 42 0.0006
838 BURNING SENSATION 39 0.0006
839 LACTIC ACIDOSIS 18 0.0006
840 PANCREATIC CARCINOMA 16 0.0006
841 BLOOD GLUCOSE INCREASED 103 0.0005
842 BLOOD GLUCOSE ABNORMAL 10 0.0005
843 SKIN HAEMORRHAGE 8 0.0005
844 IMMUNODEFICIENCY 8 0.0005
845 MENTAL IMPAIRMENT 13 0.0005
846 RESPIRATORY DISORDER 16 0.0005
847 THERAPY NON-RESPONDER 24 0.0005
848 MUSCULOSKELETAL CHEST PAIN 8 0.0005
849 ORTHOSTATIC HYPOTENSION 9 0.0005
850 GLYCOSYLATED HAEMOGLOBIN INCREASED 13 0.0005
851 DELUSION 8 0.0005
852 MOBILITY DECREASED 37 0.0005
853 HAEMORRHOIDS 10 0.0005
854 RECTAL HAEMORRHAGE 22 0.0005
855 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
856 ACUTE MYOCARDIAL INFARCTION 15 0.0005
857 RESPIRATORY ARREST 14 0.0005
858 ISCHAEMIC STROKE 9 0.0005
859 PRODUCT PRESCRIBING ERROR 12 0.0005
860 CARDIO-RESPIRATORY ARREST 21 0.0005
861 COORDINATION ABNORMAL 7 0.0005
862 CARPAL TUNNEL SYNDROME 7 0.0005
863 TOOTHACHE 9 0.0005
864 LOCALISED INFECTION 12 0.0005
865 ACCIDENTAL OVERDOSE 18 0.0005
866 BRADYCARDIA 26 0.0005
867 RIB FRACTURE 10 0.0005
868 ABASIA 12 0.0005
869 PULMONARY HYPERTENSION 10 0.0005
870 ABDOMINAL DISTENSION 50 0.0005
871 PALPITATIONS 55 0.0005
872 HAEMATOMA 12 0.0005
873 BRONCHITIS 34 0.0005
874 PRODUCT DISPENSING ERROR 10 0.0005
875 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
876 SLEEP DISORDER 32 0.0005
877 ANAPHYLACTIC REACTION 25 0.0005
878 UPPER LIMB FRACTURE 9 0.0005
879 HALLUCINATION 34 0.0005
880 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 32 0.0004
881 OXYGEN SATURATION DECREASED 25 0.0004
882 OFF LABEL USE 388 0.0004
883 GASTROENTERITIS VIRAL 8 0.0004
884 HEART RATE IRREGULAR 10 0.0004
885 BONE DISORDER 8 0.0004
886 COVID-19 77 0.0004
887 CHEST PAIN 81 0.0004
888 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
889 TREATMENT FAILURE 36 0.0004
890 CARDIOVASCULAR DISORDER 11 0.0004
891 FLUID RETENTION 22 0.0004
892 LACRIMATION INCREASED 13 0.0004
893 THINKING ABNORMAL 8 0.0004
894 HEART RATE DECREASED 15 0.0004
895 BLOOD PRESSURE INCREASED 65 0.0004
896 AGITATION 31 0.0004
897 EMOTIONAL DISORDER 13 0.0004
898 FUNGAL INFECTION 14 0.0004
899 FEMUR FRACTURE 13 0.0004
900 ANGINA PECTORIS 12 0.0004
901 CONDITION AGGRAVATED 127 0.0004
902 CARDIAC FAILURE CONGESTIVE 33 0.0004
903 WEIGHT INCREASED 92 0.0004
904 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
905 NASAL CONGESTION 24 0.0004
906 LABORATORY TEST ABNORMAL 12 0.0004
907 COLITIS ULCERATIVE 18 0.0004
908 EYE IRRITATION 23 0.0004
909 PRODUCT PHYSICAL ISSUE 8 0.0004
910 MYOCARDIAL INFARCTION 69 0.0004
911 HYPOGLYCAEMIA 19 0.0004
912 MUSCLE TWITCHING 9 0.0004
913 ANAPHYLACTIC SHOCK 10 0.0004
914 HERPES ZOSTER 22 0.0004
915 RESTLESSNESS 14 0.0004
916 DRUG INEFFECTIVE 496 0.0004
917 HEPATIC CANCER 9 0.0004
918 DEPRESSION 85 0.0004
919 CHOLELITHIASIS 12 0.0004
920 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
921 ERUCTATION 7 0.0004
922 ANGIOEDEMA 16 0.0004
923 EAR PAIN 7 0.0004
924 SURGERY 21 0.0004
925 INSOMNIA 95 0.0004
926 TYPE 2 DIABETES MELLITUS 12 0.0004
927 PRODUCT DOSE OMISSION ISSUE 104 0.0004
928 INTENTIONAL DOSE OMISSION 10 0.0004
929 TINNITUS 16 0.0003
930 MIGRAINE 33 0.0003
931 RENAL INJURY 10 0.0003
932 IMPAIRED HEALING 11 0.0003
933 DISTURBANCE IN ATTENTION 18 0.0003
934 CHEST DISCOMFORT 34 0.0003
935 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 67 0.0003
936 MOOD ALTERED 9 0.0003
937 DRUG ADMINISTRATION ERROR 10 0.0003
938 PROCEDURAL PAIN 9 0.0003
939 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
940 FLUSHING 32 0.0003
941 ANXIETY 89 0.0003
942 SINUSITIS 32 0.0003
943 SKIN IRRITATION 14 0.0003
944 LIMB INJURY 8 0.0003
945 GASTRIC CANCER 7 0.0003
946 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
947 MUSCULOSKELETAL STIFFNESS 24 0.0003
948 ARTHROPATHY 15 0.0003
949 CORONARY ARTERY DISEASE 8 0.0003
950 EAR INFECTION 7 0.0003
951 RHINORRHOEA 17 0.0003
952 BLOOD CHOLESTEROL INCREASED 12 0.0003
953 MOOD SWINGS 8 0.0003
954 BLOOD GLUCOSE DECREASED 12 0.0002
955 ADVERSE EVENT 23 0.0002
956 OSTEOPOROSIS 10 0.0002
957 NIGHTMARE 8 0.0002
958 VAGINAL HAEMORRHAGE 10 0.0002
959 MULTIPLE SCLEROSIS 11 0.0002
960 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
961 NO ADVERSE EVENT 38 0.0002
962 DEVICE DISLOCATION 9 0.0002
963 ANGER 7 0.0002
964 THROAT IRRITATION 9 0.0002
965 DRUG DOSE OMISSION 33 0.0002
966 PRODUCT DOSE OMISSION 13 0.0002
967 EXTRA DOSE ADMINISTERED 8 0.0002
968 DYSKINESIA 8 0.0002
969 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
970 CRYING 7 0.0002
971 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
972 WHEEZING 11 0.0002
973 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
974 SKIN BURNING SENSATION 13 0.0002
975 ABNORMAL BEHAVIOUR 7 0.0002
976 COLORECTAL CANCER 8 0.0002
977 IRRITABILITY 9 0.0001
978 TREATMENT NONCOMPLIANCE 8 0.0001
979 CHRONIC KIDNEY DISEASE 11 0.0001
980 RHEUMATOID ARTHRITIS 16 0.0001
981 CONVULSION 8 0.0001
982 PSORIASIS 18 0.0001
983 UNDERDOSE 10 0.0001
984 UNEVALUABLE EVENT 10 0.0001
985 BREAST CANCER 12 0.0001
986 INJURY 9 0.0001
987 PROSTATE CANCER 10 0.0001
988 OVERDOSE 26 0.0001
989 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
990 ASTHMA 9 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
992 EMOTIONAL DISTRESS 8 0.0001